bluebird bio Ownership | Who Owns bluebird bio?
bluebird bio Ownership Summary
bluebird bio is owned by 32.16% institutional investors, 0.63% insiders, and 67.21% retail investors. Blackrock is the largest institutional shareholder, holding 14.15% of BLUE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in bluebird bio shares.
BLUE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | bluebird bio | 32.16% | 0.63% | 67.21% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 15.44M | 14.15% | $15.20M |
| Vanguard group | 10.30M | 9.44% | $10.14M |
| Ameriprise financial | 6.39M | 5.86% | $6.29M |
| Millennium management | 5.15M | 4.72% | $5.07M |
| Palo alto investors lp | 4.63M | 4.25% | $4.56M |
| Geode capital management | 4.52M | 4.14% | $4.45M |
| State street | 3.80M | 3.48% | $3.74M |
| Fmr | 2.30M | 2.10% | $2.26M |
| Northern trust | 1.62M | 1.48% | $1.59M |
| Aqr capital management | 1.33M | 1.22% | $1.22M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lion point capital, lp | 678.26K | 1.22% | $667.54K |
| Palo alto investors lp | 4.63M | 0.53% | $4.56M |
| Birchview capital, lp | 311.20K | 0.28% | $306.28K |
| Summit x | 582.46K | 0.13% | $577.50K |
| Orion investment | 225.76K | 0.09% | $222.20K |
| Masters capital management | 975.00K | 0.05% | $959.60K |
| Virtu financial | 277.77K | 0.02% | $273.00K |
| Enterprise bank & trust | 30.00K | 0.01% | $29.53K |
| Sargent investment group | 38.52K | 0.01% | $37.91K |
| Allegheny financial group | 25.00K | 0.01% | $24.61K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Aqr capital management | 1.33M | 0.00% | 1.01M |
| Mirae asset global etfs | 457.42K | 0.00% | 457.42K |
| Deutsche bank ag\ | 1.17M | 0.00% | 443.24K |
| State street | 3.80M | 0.00% | 370.41K |
| Summit x | 582.46K | 0.13% | 352.69K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Granahan investment management | - | - | -7.71M |
| Tang capital management | - | - | -2.50M |
| Pfm health sciences, lp | - | - | -2.04M |
| Two sigma investments, lp | 907.98K | 0.00% | -1.87M |
| Frazier life sciences management | - | - | -1.71M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Mirae asset global etfs | 457.42K | 0.00% | 457.42K | $450.19K |
| Orion investment | 225.76K | 0.09% | 225.76K | $222.20K |
| Corebridge financial | 103.10K | 0.00% | 103.10K | $101.47K |
| Allegheny financial group | 25.00K | 0.01% | 25.00K | $24.61K |
| Vanguard personalized indexing management | 19.38K | 0.00% | 19.38K | $19.08K |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -3.00 |
| Concord wealth partners | -4.00 |
| Headlands | -6.00 |
| Nelson, van denburg & campbell wealth management group | -23.00 |
| Rothschild investment | -120.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 141 | -9.03% | 62,348,731 | -20.43% | 32 | 0.62% | 54 | -12.90% | 43 | -8.51% |
| Jun 30, 2024 | 154 | -7.23% | 78,352,735 | -23.87% | 71 | 0.81% | 61 | -29.07% | 47 | 14.63% |
| Mar 31, 2024 | 166 | -16.16% | 102,924,462 | -21.06% | 94 | 0.66% | 86 | -25.86% | 41 | 2.50% |
| Dec 31, 2023 | 198 | 13.14% | 130,383,447 | 45.79% | 119 | 1.77% | 116 | 61.11% | 40 | -14.89% |
| Sep 30, 2023 | 175 | -5.41% | 89,432,819 | -4.40% | 82 | 1.00% | 72 | -23.40% | 47 | 14.63% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.86M | 3.02% | - |
| iShares Russell 2000 ETF | 5.39M | 2.77% | -11.26K |
| ACATIS Datini Valueflex Fonds A | 3.30M | 1.70% | 30.43K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.19M | 1.65% | - |
| Fidelity Select Pharmaceuticals Port | 2.23M | 1.15% | - |
| Fidelity Small Cap Index | 1.97M | 1.02% | -16.88K |
| iShares Russell 2000 Value ETF | 1.89M | 0.97% | 2.44K |
| M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc | 1.81M | 0.93% | 86.07K |
| iShares Biotechnology ETF | 1.27M | 0.65% | 1.29K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 1.17M | 0.61% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2024 | Obenshain Andrew | President and CEO | Sell | $405.20 |
| Dec 10, 2024 | Colvin Richard A | Chief Medical Officer | Sell | $1.18K |
| Sep 30, 2024 | Klima Thomas J | See Remarks | Sell | $528.85 |
| Sep 30, 2024 | Obenshain Andrew | President and CEO | Sell | $18.27K |
| Jun 03, 2024 | Klima Thomas J | See Remarks | Sell | $3.73K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 8 |
| 2023 Q4 | - | 3 |
BLUE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools